Catamaran Bio Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie Taps Anima’s mRNA Platform, Immu

Houman Ashrafian, managing partner at SV Health Investors, sat down with In Vivo to discuss insights for investment strategies and the future of biotech in the UK. Ashrafian is based in London and h

Biopharmaceutical venture capital fundraising has not slowed its record-breaking pace during the holiday season and the VC boom has extended to life science tools and services, including two recent me